Phase 1/2a safety, tolerability, PK and PD study of AKCEA-APOCIII-LRx in healthy volunteers with elevated triglycerides

Educational partners and supporters (others pending)

Akcea Ionis logo 2021
Amarin Logo
Kowa Logo
Pfizer Logo